Dupont Capital Management’s Globus Medical GMED Stock Holding History

Dupont Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-42,684	Closed	-$2.42M	–	668
2023 Q1	$2.42M	Buy	+42,684	New	+$2.74M	0.12%	93
2020 Q3	–	Sell	-26,043	Closed	-$1.24M	–	1336
2020 Q2	$1.24M	Sell	26,043 -5,385	-17%	-$260K	0.03%	442
2020 Q1	$1.34M	Sell	31,428 -22,772	-42%	-$1.13M	0.03%	380
2019 Q4	$3.19M	Buy	54,200 +14,310	+36%	+$777K	0.07%	233
2019 Q3	$2.04M	Sell	39,890 -460	-1%	-$21.9K	0.05%	334
2019 Q2	$1.71M	Buy	40,350 +11,179	+38%	+$485K	0.04%	405
2019 Q1	$1.44M	Sell	29,171 -42,604	-59%	-$1.93M	0.03%	443
2018 Q4	$3.11M	Buy	71,775 +20,224	+39%	+$1.01M	0.08%	254
2018 Q3	$2.93M	Buy	51,551 +20,204	+64%	+$1.06M	0.06%	291
2018 Q2	$1.58M	Buy	+31,347	New	+$1.63M	0.04%	437

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Dupont Capital Management's GMED Position: Q2 2023 in Review

Dupont Capital Management sold out of Globus Medical (GMED) in Q2 2023, closing a stake of 42,684 shares — an estimated $2.42M sold.

Dupont Capital Management first reported a position in GMED in Q2 2018 and held it in 10 quarters. The position peaked at $3.19M in Q4 2019. 382 funds tracked by Wall St. Rank hold GMED as of Q2 2023.

Dupont Capital Management reported no remaining Globus Medical position as of Q2 2023 after selling out during the quarter.
Dupont Capital Management sold 42,684 Globus Medical shares in Q2 2023, an estimated $2.42M.
Dupont Capital Management first reported a position in Globus Medical in Q2 2018 and held it in 10 quarters.
Dupont Capital Management's Globus Medical position peaked at $3.19M in Q4 2019.
382 funds tracked by Wall St. Rank held Globus Medical as of Q2 2023.

Based on Dupont Capital Management's 13F filing for Q2 2023, filed 25 Jul 2023.